Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with anticipated difficult intubation. 2. Patients aged between 18 - 65 years of both genders who upon being explained the procedure are willing to participate in the study.
Exclusion criteria
Exclusion criteria: 1. Patients who are uncooperative to awake fiberoptic intubation. 2. Patients allergic to lignocaine, xylometazoline, phenylephrine or glycopyrrolate. 3. Patients with uncontrolled diabetes mellitus, hypertension or heart block. 4. Patients who are on beta-blockers. 5. Patients with a history of bleeding diathesis. 6. Patients with bradyarrhythmia. 7. Asthmatic patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the efficacy of dexmedetomidine nebulization and plain lignocaine so as to achieve successful airway assessment to assess the quality of airway anaesthesia to assess patient comfort score on basis of number of attempts of cough,gag reflex and hemodynamic stability. Time Points : 4weeks, 8weeksTimepoint: To compare the efficacy of dexmedetomidine nebulization and plain lignocaine so as to achieve successful airway assessment to assess the quality of airway anaesthesia to assess patient comfort score on basis of number of attempts of cough,gag reflex and hemodynamic stability. Time Points : 4weeks, 8weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare patient sedation in both groups and to assess the complication if any occurs during awake fiber-optic intubation.Timepoint: To compare patient sedation by using Ramsay Sedation Score (1 to 6 Scale). Estimated i.e. at baseline, 4 weeks and 8 weeks | — |
Countries
India
Contacts
Himalayan Institute of Medical Sciences, Swami Rama Himalayan University